PACS Group, Inc.

PACS ·Healthcare, Medical Care Facilities, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022
Revenue $5.29B $4.09B $3.11B $2.42B
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense $415.1M $343.8M $213.7M $149.0M
Operating Income $309.6M $123.1M $207.8M $229.4M
Operating Margin 5.9% 3.0% 6.7% 9.5%
Interest Expense
Pretax Income $284.5M $101.6M $157.3M $207.0M
Income Tax Expense $93.0M $46.2M $44.4M $56.5M
Net Income $191.5M $55.8M $112.9M $150.5M
Net Margin 3.6% 1.4% 3.6% 6.2%
EPS (Basic) $1.23 $0.38 $0.88 $1.17
EPS (Diluted) $1.22 $0.38 $0.88 $1.17
Shares Outstanding (Basic) 156.2M 146.7M 128.7M 128.7M
Shares Outstanding (Diluted) 156.7M 148.6M 128.7M 128.7M
Dividends Per Share $0.22 $0.62 $0.47